Who Gets Expensive Cancer Drugs? A Tale of Two Nations
There is a strong notion that patients in the United States have unfettered access to the most expensive cancer drugs. This article has a team of bioethicists and health policy experts explaining how the United Kindom's nationalized health care system regularly denying access to some high-cost treatments needs rethinking.
No comments:
Post a Comment